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CASE REPORTS - 
Intracoronary Verapamil for Reversal of efractory Coronary 
Vasospasm During Percutaneous Translurnminal Coronary Gngio 
DAVID G. BABBITT, MD, JAMES M. PERRY. MD. FACC, MERVYN B. FORMAN. MD, FACC 
Nasiwille. Tennessee 
Coronary artery spasm unresponsive to intracoronary 
nitroglycerin was observed in eight patients undergoing 
percutaneous transluminal coronary angioplasty ror 
unstable iscbemic symptoms (unstable angina or recent 
nontransmural infarction, or both). All patients mani- 
fested eccentric lesions an&graphically with the right 
coronary artery involved in four, circumflex artery in 
two and IeR anterior descending in two. Severe coronary 
spasm was documented angiugraphicatly in all patients 
after angioptasty ar.d resulted in symptomatic and 
electrocardiographic evidence of ischemia. Multiple 
The incidence rate of coronary vasospasm complicating 
percutaneous transluminal coronary angioplasty is conserv- 
atively estimated to be 4% (1.2). In patients undergoing 
“emergent” procedures for the treatment of acute myocar- 
dial infarction or unstable angina, the incidence is probably 
higher. The finding of increased vasoreactivity at the site of 
prior angioplasty in both humans (3-5) and the swine model 
(6) supports a causal relation between enhanced reactivity 
and endothelial cell damage. The presence of a complex 
atherosclerotic plaque associated with platelet deposition 
and endothelial cell dysfunction may predispose the dilated 
vessel to both an enhanced and a prolonged increase in 
vasomotor tone after balloon dilation. 
Coronary spasm that develops after balloon angioplasty 
may be refractory to medical therapy. Occasionally. high 
doses of intracoronary nitroglycerin are required to relieve 
spasm and in rare cases emergent coronary artery bypass 
surgery is indicated for refractory spasm. We describe eight 
patients who developed severe coronary spasm after balloon 
angioplasty and failed to respond to intracoronary nitroglyc- 
erin. The administration of intracoronary verapamil resulted 
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sites of spasm were present in the dilated vessel io three 
patients. 
Coronary artery spasm persisted despite the infusion of 
large doses of intraroronary nitroglycerin (200 to 2,ooQ pg, 
mean 850 pg) over 10 min. Administration of intrxoronary 
verapamil (1 to 1.5 mg over 10 min) resulted in complete 
relief of sprn with restoration of brisk anterugrade ftow in 
all patients. These findings suggest that intracoronary vera- 
pamil may be a usefbl agent for the relief of coronary spasm 
occurring in the setting of conmary angio*ty. 
(J Am Cdl Cdol1988;12:1377-81) 
in successful reversal of spasm in all patients without ad- 
verse electrocardiographic (ECG) or hemodynamic effects. 
Case Reports 
Study patients. During the period from January to De- 
cember 1987. percutaneous balloon coronary angioplasty 
was performed on 224 lesions at Vanderbilt University 
Medical Center. Severe coronary artery spasm of the dilated 
vessel, which was unresponsive to intracoronary nitroglyc- 
erin. was observed in eight patients who form the basis of 
this report. Their ages ranged from 39 to 75 years (mean 57); 
there were six men and two women. None of the patients 
had a prior history of variant angina. Angiography of both 
coronary vessels was performed in multiple views with and 
without angulation. The percent hmiwd: narrowing was 
determined from two views with a manuai caliper method. 
All patients had a fixed stenosis of 275% iuminal reduction 
of the vessel to be dilated. Administration of aspirin (325 mg 
daily) and a calcium channel b!ocker (diltiazem. mean daily 
dose 120 mg; or nifedipine, mean daily dose 30 mg) was 
begun rl day before angioplasty was performed. 
Coronary angioplasty. The procedure was performed 
with the technique described by Gruentzig et al. (7), which 
utilized a steerable guide wire system. After arterial access 
was obtained, all patients received 10,000 U of intravenous 
heparin and IO mg of sublingual nifedipine. All lesions were 
successfully crossed and dilation resulted in a significant 
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Table 1. Clinical and Angiographic Findings in Patients Who Developed Coronary Spasm After Percutaneous Balloon Angioplasty 
Gradient 
Age (yr) % Stenosis 
case & Artery ~ Chawcter 
(mm Hgl ” Verapamil 
NTG - Angiographic 
No. Gender Clinical Chacteriks Involved Pre Post of Lesion Type* Pre Post w IC IV Comments 
I 45M 7 dayr po\~ SEMI Proximal x0 30 ECC. ULC. II 20 7 1500 1.0 0,s Z linear intimal 
RCA SEG tears after spasm: 
3 sites of spasm 
? 55F Resl and exertional Proximal 75 IS ECC. FOC II 35 19 900 1.5 0.5 1 sites of spasm 
chebt pain RCA 
3 69M Resl illld exertional Proximal 75 20 ECC. SEG I 30 II 6Ml 1.5 I.0 Intimal tear 
chc~~ pain LAD 
4 6XM Re\t illld exertionul Di~lal 85 30 ECC. SEC II 54 14 2lMO I.0 0.5 lntimal tear (I cm 
chest pain RCA length) residual 
thrombus 
5 4lM 4 day\ po+inferior Mid LCx 95 25 ECC. SEG I 71 I? 500 1.0 - Sequential lesions: 
Ml: resl pain 80 20 ECC. SEG II residual 
thrombus 
6 42M Rest and exertional Mid RCA 75 40 ECC. SEG I 17 0 7tltl I.0 0.5 2 to 3 sites of 
chest pair spasm 
7 75F Rest and exertiona Mid LCx 90 ICI ECC. SEG I None 20-J 1.0 0.5 Long segmenlol 
cheyl pam !Kl IO ECC. SEG I spasm: sequential 
lesions 
8 hOM Rest and excnional Mid LAD 99 40 ECC. FOC I 70 2 400 1.0 - Spasm distal lo 
chesl pain dilation sik 
*Angiographrc appearance of lesion as defined by Ambrose et al. (X.91. ECC = eccentric: F = female: FOC = focal: IC = intracoronary: IV = intravenous: 
LAD = left anterior dewzending coronary artery: M = male: LCx = fell circumflex coronary artery: NTG = nitroglycerin: RCA = right coronary artery; SEG 
= segmem: SEMI = subendocardial myocardial infarclion. 
reduction in both the angiographic stenosis and hemody- 
namic pressure gradient (Table i). Focal severe coronary 
spasm was observed in ail patienls xfler w+oplasty resulting 
in ischemic chest pain and c segment ‘wation on a 
monitored ECG lead. ‘IIK spastic segmem involved the 
dilated segment and varied in length from 2 lnm to 2 ems 
(Fig. I). Multiple segments of spasm were evident in three 
patients (Cases I. 2, 6). In one patient (Case 4) coronary 
spasm was complicated by ventricular tachycardia and fibril- 
lation requiring cardioversion. The administration of large 
doses of intracoronary nitroglycerin (m&an 850 pg) over 
approximately 10 to I5 min failed to restore the luminal 
diameter of the spastic segments to baseline. 
CWLW~Q~ arrgiogrwrr,~~ were retrospectively reviewed by 
two independent observers IO assess the presence of inrimal 
tears or dissection in the dilated vessel. An intimal tear, 
defined as discontinuity of < I cm in the arterial wall without 
contrast retention, was present in three patients (Cases I, 3, 
4). Angiographic discontinuity of >I cm in length with 
contrast retention (dissection) was not visualized in any 
patient. 
Method of intracoronary verapamil administration. Vera- 
parnil (I mg) diluted in IO ml of normal saline solution was 
infused manually at a rate of 100 pglmin through the balloon 
catheter positioned just proximal to the vasospastic segment 
over a IO min period. Continuous ECG monitoring was 
performed for evidence of PR or QRS prolongation. atrio- 
ventricular block or arrhythmias. In the majority of patients 
complete resolution of spasm was noted at the end of the 
infusion of I mg (IO min) (Fig. 1). In two patients (Cases 2 
and 3), only partial relief was observed at this dose, and the 
infusion of an additional 0.5 mg over 5 min was required. No 
significant conduction abnormalities or infusion-related 
arrhythmias were observed. No significant change in blood 
pressure or heart rate was identified during the infusion in 
any patient. Six of the eight patients were empirically given 
an intravenous verapamil infusion of 0.5 to 1.0 mg/h for 24 h 
after the procedure No complication of hypotension. heart 
block, prolonged ventricular conduction or arrhythmia was 
associated with this therapy. 
Ffgure 1. Case 6. Angiogram of right coronary artery in the left 
anterior oblique projection from a 42 year old man with unstable 
angina. A, A moderate lesion is present in the mid segment (arrow). 
B, After angioplasty. a focal area of spasm is noted at the site of 
dilation, resulting in subtotal occlusion (arrow). C, After intracoro- 
nary verapamil, relief of spasm is evident. 
the most frequently involved vessel, which is compatible 
with findings in patients with either spontaneous or ergono- 
vine-induced coronary spasm. All patients presented with an 
unstable ischemic syndrome and coronary angiography dem- 
onstrated complex eccentric lesions as described by Am- 
brose et al. (8,9). Althougb intracoronary nitroglycerin in- 
variably relieves spontaneous and pharmacologically 
precipitated spasm, large doses in our patients were ineffec- 
tive. The reasons for this result remain speculative but may 
be related to different pathogenetic mechanisms in the set- 
ting of coronary angioplasty, nitrate tol&ance or greater 
potency of verapanB as an antispasmodic agent. 
A@0graphk and patboI0giC findings in unstab!e angina. 
Although alterations in vasomotor tone play an important 
role in various ischemic heart syndromes, their cause or 
causes remain poorly defined. Advances in techniques of 
visualizing the coronary vasculature in vivo, detailed patho- 
logic studies and pharmacologic manipulations in experi- 
mental models have broadened concepts that may modify 
vasoreactivity of epicardial vessels. 
Angiographic studies have demonstrated a marked dis- 
parity in the appearance of atheromatous lesions in patients 
with stable and unstable angina (8.9). During the unstable 
phase. the majority of the lesions were eccentric with 
overhanging edges or irregular scalloped borders with a 
shallow neck. These angiographic appearances were be- 
lieved to represent an unstable lesion with associated plaque 
rupture and adherent thrombus. These lesions were rarely 
observed during the stable phase. Coronary angioscopy has 
also been useful in further elucidating the nature of athero- 
matous lesions in ischemic syndromes (IO). Intraoperative 
angioscopy in patients with unstable angina has demon- 
sttated that the endothelium is denuded and ulcerated in 
association with the presence of intimal hemorrhage and 
adherent thrombus formation. In contrast, angioscopy in 
patients with stable angina invariably demonstrates an intact 
endothelium without thrombus. Numerous pathologic stud- 
ies have confirmed observations obtained at angioscopy (1 I). 
Possible mechanic of coronary spasm. The large sur- 
face area occupieQ by the endothelium of the coronary 
vasculature suggests that it plays an important role in 
modulating coronary vascular tone. A number of compounds 
such as endothelial-derived relaxation factor. adenosine rend 
prostacyclin are produced by the functionally intact endo- 
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thelium and these reduce vascular tone or inhibit plateiet 
aggregation, or both. Infusion of the endothelial-dependent 
vasodilator, acetylcholine, in patients with coronary disease 
results in paradoxical vasoconstriction (12). Van Benthuy- 
sen et al. (13) demonstrated that endothelial damage in an 
open chest canine model of myocardial reperfusion injury 
resulted in augmented epicardial vascular tone in response to 
vasoconstrictors, which was attenuated by verapatuil ther- 
apy. Verapamil also restored endorhelial dependent relax- 
ation with acetylcholine comparable with relaxation ob- 
served in nonischemic segments, possibly by reducing 
calcium influx into the cell and thereby stabilizing cellular 
membranes. A similar local modulation of calcium influx 
may be responsible for the spasmolytic effect observed in 
our patients. 
Platelet activation at the site of a complex atheromatous 
plaque may also contribute to enhancing vasomotor tune. 
Endothelial cell injury in the canine mode! produces cyclical 
flow variations that are abolished by inhibitors or receptor 
blockers of platelet secretory products such as thromboxane 
and serotonin (14,15). Platelets accumulate rapidly at the site 
of mechanical injury produced by balloon angioplasty, and 
reactivity of the vessel is increased in proportion to the 
number of platelets deposited (6). 
Cellular inJilrrarion of the atherosclerotic vessel wall may 
be another source of potential vasoconstrictor substances. 
Mast ceils increase in the adventitia as atherosclerosis 
progresses. Mast cells have been found to be more prevalent 
in patients who die suddenly and have a hemorrhagic plaque 
and were found in one patient who had documented variant 
angina during life (16). Mast cells produce a variety of 
vasoconstrictor substances such as histamine, prostaglandin 
D, and leukotrienes. Neovascularization is frequently prom- 
inent in regions of atherosclerosis and could facilitate deliv- 
ery of mast cell secretory products to smooth muscie in the 
media (17). 
Postangioplasty spasm in the eight reported patients. Se- 
vere coronary artery spasm was observed in eight patients 
who underwent percutaneous coronary angioplasty for the 
treatment of unstable coronary syndromes. All patients 
demonstrated complex lesions at angiography that have been 
shown to correlate with plaque rupture histologically. Such 
patients with complex atheromatous lesions may be at 
increased risk for coronary spasm at the site of further 
vascttlar injury produced by the angioplasty procedure. 
Angioplasty may enhance endothelial injury, promote fur- 
ther platelet deposition and increase release of cellular 
vasoconstrictor factors. The eight patients in our study 
developed severe coronary spasm in the setting of unstable 
ischemic syndromes and complex atherosclerotic lesions on 
angiography. Intermittent occlusion has been noted in pa- 
tients undergoing successful repetfusion with streptokinase 
and this occlusion is abolished with intracoronary nitroglyc- 
erin (18). Further studies appear warranted to determine the 
contribution of spasm to reocclusion in patients treated with 
thrombolytic therapy or balloon angioplasty for evolving 
myocardial infarction. 
Role of intracoronary verapamti. Whereas high dose in- 
tracoronary nitroglycerin failed to relieve the coronary 
spasm, 1 to 1.5 mg of intracoronaj verapamil resulted in 
rapid resolution of the vasospastic segment angiographically 
and normalization of the ECG in all eight cases. No adverse 
hemodynamic or ECG effects were observed during verapa- 
mil administration. Verapamil appears to be a highly effec- 
tive therapeutic agent for the relief of coronary vasospasm 
that occurs after angioplasty and is unresponsive to intracor- 
onary nitrates. 
We thank Carolyn Coffey for expert secretarial assistance. 
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